Furthermore, genetic suppression or pharmacologic inhibition of SLC25A1 significantly inhibited tumor growth and metastasis in a variety of common human cancer cell lines, whereas SLC25A1 overexpression enhanced the malignant phenotype [7, 10, 15]. This evidence concerns the gene SLC25A1 and cancer.